Search Results - "Groene, S."

Placental characteristics in monochorionic twins with selective intrauterine growth restriction in relation to the umbilical artery Doppler classification by Groene, S.G., Tollenaar, L.S.A., Slaghekke, F., Middeldorp, J.M., Haak, M., Oepkes, D., Lopriore, E.

“…The objective of this study was to evaluate the placental characteristics of monochorionic twin pregnancies with selective intrauterine growth restriction…”
Get full text

Outcome of monochorionic twin pregnancy complicated by Type‐III selective intrauterine growth restriction by Shinar, S., Xing, W., Pruthi, V., Jianping, C., Slaghekke, F., Groene, S., Lopriore, E., Lewi, L., Couck, I., Yinon, Y., Batsry, L., Raio, L., Amylidi‐Mohr, S., Baud, D., Kneuss, F., Dekoninck, P., Moscou, J., Barrett, J., Melamed, N., Ryan, G., Sun, L., Van Mieghem, T.

“…ABSTRACT Objective Type‐III selective intrauterine growth restriction (sIUGR) is associated with a high and unpredictable risk of fetal death and fetal brain…”
Get full text

Artery-to-vein anastomoses in unequally divided placentas and their association with birthweight discordance by Noll, A.T.R., Lof, F.C., Groene, S.G., Haak, M.C., Lopriore, E., Russo, F.M., Slaghekke, F., Tollenaar, L.S.A., Van der Merwe, J., Verweij, E.J.T., Lewi, L.

“…This study investigated the impact of the shared intertwin circulation in unequally divided monochorionic (MC) placentas on fetal growth. This retrospective…”
Get full text

Changes in structural brain development after selective fetal growth restriction in monochorionic twins by Groene, S. G., Vries, L. S., Slaghekke, F., Haak, M. C., Heijmans, B. T., Bruin, C., Roest, A. A. W., Lopriore, E., Klink, J. M. M., Steggerda, S. J.

“…Objectives Fetal growth restriction (FGR) may alter brain development permanently, resulting in lifelong structural and functional changes. However, in studies…”
Get full text

OP04.02: Growth patterns of monochorionic twin pregnancies complicated by type‐3 selective fetal growth restriction by Shinar, S., Pruthi, V., Jiang, Y., Xing, W., Jianping, C., Lewi, L., Couck, I., Slaghekke, F., Groene, S., Lopriore, E., Yinon, Y., Batsry, L., Raio, L., Amylidi‐Mohr, S., Baud, D., Kneuss, F., De Koninck, P., Moscou, J., Barrett, J., Melamed, N., Ryan, G., Huszti, E., Sun, L., Mieghem, T.

Get full text

VP43.21: Outcomes of monochorionic twin pregnancies complicated by type III selective fetal growth restriction by Shinar, S., Xing, W., Pruthi, V., Jianping, C., Slaghekke, F., Groene, S., Lopriore, E., Lewi, L., Couck, I., Yinon, Y., Batsry, L., Raio, L., Amylidi‐Mohr, S., Baud, D., Kneuss, F., De Koninck, P., Moscou, J., Barrett, J., Melamed, N., Ryan, G., Sun, L., van Mieghem, T.

Get full text

Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers by Pecora, Andrew L, Rizvi, Naiyer, Cohen, Gary I, Meropol, Neal J, Sterman, Daniel, Marshall, John L, Goldberg, Stuart, Gross, Peter, O'Neil, James D, Groene, William S, Roberts, M Scot, Rabin, Harvey, Bamat, Michael K, Lorence, Robert M

“…PV701, a replication-competent strain of Newcastle disease virus, causes regression of tumor xenografts after intravenous administration. This phase I study…”
Get full text

A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization by LAURIE, Scott A, BELL, John C, ATKINS, Harold L, ROACH, Joanne, BAMAT, Michael K, O'NEIL, James D, SCOT ROBERTS, M, GROENE, William S, LORENCE, Robert M

“…Purpose: In a previous phase 1 study, adverse events, especially flu-like symptoms, were observed mainly following the first i.v. bolus dose of PV701, an…”
Get full text

An Optimized Clinical Regimen for the Oncolytic Virus PV701 by HOTTE, Sébastien J, LORENCE, Robert M, HIRTE, Hal W, POLAWSKI, Susan R, BAMAT, Michael K, O'NEIL, James D, SCOT ROBERTS, M, GROENE, William S, MAJOR, Pierre P

“…Purpose: Previous phase 1 trials of i.v.-administered PV701 have shown this virus to be well-tolerated with toxicity primarily associated with the first dose…”
Get full text

Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus by Lorence, Robert M, Roberts, M Scot, O'Neil, James D, Groene, William S, Miller, Jeffrey A, Mueller, Stephen N, Bamat, Michael K

“…PV701 is a naturally-attenuated, non-recombinant, oncolytic strain of Newcastle disease virus that displays preclinical intravenous (IV) efficacy. PV701 is…”
Get more information

Psoralen preparation of antigenically intact noninfectious rotavirus particles by Groene, W S, Shaw, R D

“…The use of the synthetic psoralen 4'-aminomethyl-4,5',8-trimethylpsoralen hydrochloride (AMT) is described for the inactivation of infectious rotavirus, a…”
Get more information

Growth patterns of monochorionic twin pregnancy complicated by Type‐III selective fetal growth restriction by Shinar, S., Xing, W., Lewi, L., Slaghekke, F., Yinon, Y., Raio, L., Baud, D., DeKoninck, P., Melamed, N., Huszti, E., Sun, L., Van Mieghem, T., Pruthi, V., Jianping, C., Couck, I., Jiang, Y., Groene, S., Lopriore, E., Batsry, L., Amylidi‐Mohr, S., Kneuss, F., Moscou, J., Barrett, J., Ryan, G.

“…ABSTRACT Objectives Little is known regarding fetal growth patterns in monochorionic twin pregnancy complicated by Type‐III selective fetal growth restriction…”
Get full text

Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year by SHAW, R. D, MERCHANT, A. A, GROENE, W. S, CHENG, E. H

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Murine intestinal antibody response to heterologous rotavirus infection by MERCHANT, A. A, GROENE, W. S, CHENG, E. H, SHAW, R. D

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection by SHAW, R. D, GROENE, W. S, MACKOW, E. R, MERCHANT, A. A, CHENG, E. H

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

55. Translating Preclinical Results into the Clinical Development of PV701, an Oncolytic Virus by Lorence, Robert M., Scot Roberts, M., O'Neil, James D., Buasen, Pete T., Zhang, Li, Groene, William S., Bamat, Michael K.

“…PV701 is an attenuated, non-recombinant oncolytic Newcastle disease virus that is naturally tumor selective by exploiting cancer- specific defects in the…”
Get full text

Overview of phase I studies of intravenous administration of PV701, an oncolytic virus by Lorence, Robert M, Pecora, Andrew L, Major, Pierre P, Hotte, Sebastien J, Laurie, Scott A, Roberts, M Scot, Groene, William S, Bamat, Michael K

“…PV701 is an attenuated, non-recombinant, oncolytic strain of Newcastle disease virus that displays preclinical intravenous (i.v.) efficacy. PV701 selectively…”
Get more information

Recombinant baculovirus-expressed rotavirus protein (VP4) in an ELISPOT assay of antibody secretion by Shaw, R D, Groene, W S, Mackow, E R, Merchant, A A, Cheng, E H

“…Studies on the protein specificity of the intestinal antibody response to rotavirus infection have been hampered by lack of antigenically conserved isolated…”
Get more information

Naturally occurring viruses for the treatment of cancer by Roberts, M Scot, Groene, William S, Lorence, Robert M, Bamat, Michael K

“…The use of naturally occurring viruses in the treatment of cancer is not new, and reports describing the administration of viruses to cancer patients date back…”
Get more information

Gestational age at birth and outcome in monochorionic twins with different types of selective fetal growth restriction: A systematic literature review by el Emrani, Salma, Groene, Sophie G., Verweij, E. Joanne, Slaghekke, Femke, Khalil, Asma, Klink, Jeanine M. M., Tiblad, Eleonor, Lewi, Liesbeth, Lopriore, Enrico

“…This systematic review aims to assess the gestational age at birth and perinatal outcome [intrauterine demise (IUD), neonatal mortality and severe cerebral…”
Get full text